Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)
NCT07225530
Summary
This study aims to conduct a randomized controlled trial to evaluate the effectiveness of same-day HPV-based screen and treat among women living with HIV (WLH) in La Romana, Dominican Republic. With cervical cancer being a leading cause of cancer-related deaths in women living with HIV, and cervical cancer deaths being preventable through screening and early detection, this project seeks to identify factors associated with the successful implementation of the Screen, Triage, and Treat approach to inform future implementation and scale-up.
Eligibility
Inclusion Criteria: * 25 years of age; * female sex assigned at birth (any gender identity); * HIV-positive; * women who have had cervical cancer precursor lesions which were removed more than 6 months ago; and * understand Spanish Exclusion Criteria: * ages outside of the specified inclusion criteria; * women who are pregnant, less than 6 weeks postpartum, or in whom pregnancy cannot be excluded; * history of a Loop Electrosurgical Excision Procedure (LEEP) procedure in the last 6 months; * history of a hysterectomy; * previous diagnosis of gynecological cancer; * history of cancer of the anogenital tract; or * unable or unwilling to provide informed consent
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07225530